logo

Eyenovia, Inc. (EYEN)



Trade EYEN now with
  Date
  Headline
12/29/2020 7:10:34 AM Eyenovia Submits NDA To FDA For MydCombi
10/12/2020 7:02:34 AM Bausch Health Licenses Eyenovia's Investigational Treatment For Reduction Of Pediatric Myopia Progression In Children
8/19/2020 9:30:53 AM Eyenovia Prices Public Offering Of 3.33 Mln Shares At $3.60/Shr
8/11/2020 8:06:43 AM Eyenovia, Arctic Vision Announce Exclusive Collaboration And License Agreement
3/25/2020 4:08:20 PM Eyenovia Q4 Loss/share $0.31 Vs. Loss $0.60 Year Ago
8/12/2019 4:10:51 PM Eyenovia Q2 Loss/share $0.44 Vs. Loss $0.33 Year Ago
7/11/2019 9:08:29 AM Eyenovia Prices Public Offering Of 4.39 Mln Shares At $2.78 Per Share
7/10/2019 4:20:39 PM Eyenovia Announces Proposed Public Offering Of Common Stock
6/4/2019 8:39:49 AM Eyenovia Enrolls First Patient In Phase III CHAPERONE Study For Progressive Myopia
5/14/2019 6:39:50 AM Eyenovia Q1 Net Loss $5.9 Mln Or $0.50/Shr Vs Loss $3.4 Mln Or $0.45/Shr Last Year
3/27/2019 6:44:18 AM Eyenovia Q4 Net Loss $6.2 Mln Or $0.60/Shr Vs Loss $2.2 Mln Or $0.84/Shr Last Year
2/6/2019 8:35:21 AM Eyenovia Says FDA Accepted IND Application To Initiate CHAPERONE Study